A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says. Nemolizumab (Nemluvio) relieved itchiness within two days for three ...
Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects millions of children and adults. It often causes itching, redness, dryness, flaking, and sometimes ...
The Food and Drug Administration granted priority review status to dupilumab, an injectable antibody drug used to treat atopic dermatitis, or eczema. The drug, developed by Paris-based Sanofi and ...
About three times as many eczema patients on nemolizumab had itch relief within two days compared to placebo Twice as many eczema patients slept better within two days ...
About three times as many eczema patients on nemolizumab had itch relief within two days compared to placebo Twice as many eczema patients slept better within two days FRIDAY, Dec. 19, 2025 (HealthDay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results